Author

admin

Browsing

A current top campaign adviser for VP Kamala Harris was deeply involved in pushing Facebook to suppress ‘misinformation’ in an effort to control the political narrative on COVID and other issues.

Meta CEO Mark Zuckerberg admitted in a letter on Monday while expressing regret that his company, Facebook, was pressured by the Biden-Harris administration to censor Americans, particularly regarding COVID-19 content, bringing to the forefront actions taken by Harris’ deputy campaign manager Rob Flaherty as part of that pressure campaign.

Flaherty, who previously served as the White House director of digital strategy, helped lead the campaign to target alleged ‘misinformation’ relating to the COVID-19 virus and its vaccinations, FOX Business previously reported.

Flaherty emailed Google team members in April 2021 to ‘connect […] about the work you’re doing to combat vaccine hesitancy, but also crack down on vaccine misinformation,’ according to the documents. 

Flaherty continued asking for trends surrounding vaccine misinformation on the website, while offering government assistance in the form of COVID experts at the White House to partner in product work with YouTube. 

Google, in an internal email, noted that after a subsequent meeting with Flaherty, the White House staffer ‘particularly dug in on our decision making for borderline content’ – which is content that doesn’t cross Community Guidelines but rather brushes up against it, according to YouTube. 

A week later, Google acknowledged that it sent the White House the total amount of videos removed for COVID vaccine misinformation, while discussing the government’s desire for even more data.

‘Really [Flaherty’s] interested in what we’re seeing that is NOT coming down,’ read an internal Google email between employees, seemingly referring to videos that had not yet been removed. 

According to internal company communications viewed by FOX Business and reported on in 2023, Flaherty asked Facebook if they could provide government agencies with special access to tools to target users in 2021. 

‘Since it’s a global pandemic, can we give agencies access to targeting parameters that they normally wouldn’t be able to?’ Flaherty asked.

The idea came up in a conversation about how to convince people worried about side effects around the COVID vaccine to take it.

On an April 5 call, a Facebook employee mentioned how if someone was worried about nosebleeds as a side effect of the vaccine, in an ideal world, they would direct them to information addressing that concern. Flaherty asked the Facebook team, ‘Are you able to provide resources?’ 

Another Facebook employee replied that doing something like showing them a targeted resource addressing their concern might trigger people. The Facebook employee said they ‘have to be careful in how we approach.’ 

Flaherty asked, ‘If people are having the conversation, is the presumption that we let people have it. Direct them to CDC. What then?’ 

A Facebook employee replied, ‘We all know people that have had the experience that think that FB is listening to them.’ 

The Facebook employee told Flaherty that something like an immediate generated message about nosebleeds might give users ‘the Big Brother feel’ but suggested they show the content on a delay to avoid setting off alarm bells among users. 

‘We should pay attention to those conversations, make sure that people see information, even if it’s not right then,’ the Facebook employee said. 

Flaherty was involved in a tense exchange with GOP Rep. Jim Jordan, of Ohio, during a hearing on Capitol Hill earlier this year when Flaherty claimed that Elon Musk did not face ‘any adverse government actions’ in response to changing the outlet’s censorship policies.

Fox News Digital reached out to the White House and the Harris-Walz campaign for comment but did not receive a response.

‘Ultimately, it was our decision whether or not to take content down, and we own our decisions, including COVID-19-related changes we made to our enforcement in the wake of this pressure,’ Zuckerberg wrote in his letter to the House Judiciary Committee this week. ‘I believe the government pressure was wrong, and I regret that we were not more outspoken about it.

Fox News Digital’s Hillary Vaughn and Chase Williams contributed to this report

This post appeared first on FOX NEWS

The clock is ticking for Vice President Kamala Harris to schedule the formal interview she and her team promised would happen before the end of the month.

After formally receiving the Democratic Party’s presidential nomination, Harris told reporters on the tarmac in Detroit earlier this month that she wanted to schedule her first formal interview as the party’s nominee before the end of August. Meanwhile, the exact date, time, place and media outlet that will be conducting the interview has remained a mystery, even as Harris’ self-imposed deadline quickly approaches.

With only four days left this month, questions about the interview have been prevalent inside the beltway. Some of those questions include who on the Harris campaign is making the final interview decision, what kind of message Harris will try to send and who will be the figurehead posing the questions to her.

Harris campaign staffers have reportedly been asking journalists who they think the vice president should talk to, according to Politico. The outlet indicated CBS’ Norah O’Donnell and NBC’s Lester Holt were among the frontrunners. There has also reportedly been internal disagreements over how Harris should approach the interview.

With less than a week remaining for Harris to get something on the calendar, some journalists have begun weighing in on the process.

‘I understood why Kamala Harris wasn’t doing interviews before – she was getting her policy proposals hammered out behind the scenes before the convention. But now there are no more excuses. She needs to do interviews, a lot of them. We’re picking a president here. It’s important,’ said political commentator Cenk Uygur, host of The Young Turks, which describes itself as ‘America’s largest online progressive news network.’

‘The fact that there is so much internal turmoil over doing A SINGLE INTERVIEW is itself deeply revealing,’ conservative columnist Marc Thiessen wrote Tuesday morning on X, formerly Twitter. ‘This is not a ‘big decision.’ It exposes their lack of confidence in her and is making something that should be routine into a high stakes event.’

While the pressure on Harris to do an interview is getting greater by the day, some of her supporters have urged her to continue dodging the media. Rick Wilson, former GOP strategist and co-founder of the anti-Trump Lincoln Project, said last week that Harris ‘has no f—ing necessity to do interviews right now.’

The same opinion was echoed by legendary Hollywood director Quentin Tarantino, who told talk show host Bill Maher last Sunday that ‘sometimes it’s just about f—ing winning.’

‘I’m going to vote for her f—ing anyway, no matter what she says in the stupid f—ing interview, so don’t f— s— up,’ Tarantino added.

Harris has been utilizing a lighter than normal schedule since the Democratic National Convention concluded last week, according to Politico, which reported Harris has been using the time to prepare for her upcoming Sept. 10 debate and map out her future media strategy.

Fox News Digital reached out to both the Harris and Trump campaigns for comment. The Harris campaign did not provide a response, but the Trump campaign directed Fox News Digital to a Tuesday press release it put out, which called out Harris for going 37 days without an interview.

‘Kamala is dodging the press for a reason,’ the press release stated. ‘She doesn’t want to talk about her radical agenda.’

This post appeared first on FOX NEWS

Republican vice presidential candidate, Sen. JD Vance of Ohio, speaking near the site of a major electric vehicle battery factory project, charged that Democratic presidential candidate Vice President Kamala Harris and the current Democratic administration ‘are helping China destroy and replace our auto industry from the inside out.’

Vance held a campaign event Tuesday in Big Rapids, Michigan near where Gotion Inc., a company that, according to FARA filings, was quietly registered as a Chinese foreign principal in 2023, is planning to build a $2.4 billion electric vehicle battery plant.

Vance said that Harris’ ‘tie-breaking vote that she cast to send inflation through the roof,’ referring to the Inflation Reduction Act of 2022, made ‘Chinese companies like Gotion eligible for millions of your taxpayer dollars.’

‘Even some of the folks in Obama’s administration said that the Gotion factory plant is a threat to America’s national security,’ Vance told the audience. ‘But Kamala Harris not only wants to allow the Chinese Communist Party to build factories on American soil, she wants to pay them to do it with our tax money.’

‘Democrats in this state, and including Kamala Harris, want to give hundreds of millions of dollars to those same companies that have been undercutting Michigan autoworkers. What a disaster, isn’t it?’ he added. ‘Donald Trump has a different idea. He is going to drill, baby, drill. We’re going to unleash American workers and bring back those great factories.’

The senator also touched on the drama surrounding former President Trump’s scheduled debate with Vice President Harris after reports that the presidential nominees were clashing over debate rules ahead of the live Sep. 10 event.

‘He thinks it’s important that the American people see him debate and especially see Kamala Harris, because she’s run from the media for pretty much the entire campaign,’ Vance said in an exclusive interview with Fox News’ Aishah Hasnie at the Michigan event. ‘He also doesn’t like that they’re trying to change the rules at the very last minute, because they figured out that Kamala Harris, she’s just not that great at this.’

Vance also addressed the letter that Meta CEO Mark Zuckerberg sent to House Judiciary Committee Chairman Jim Jordan on Monday, revealing that he faced pressure from the Biden-Harris administration to censor Americans, particularly regarding COVID-19 content.

‘This should be bombshell news,’ Vance told Fox of the letter. ‘The leader of one of the most important social networks in the world just came out and said, I censored Donald Trump in the run-up to the election because there were certain elements within the Biden administration and the Biden campaign that encouraged me to do that. That is crazy. That is the revelation of censorship in a way that affected an American election.’

Fox News’ Aishah Hasnie contributed to this report.

This post appeared first on FOX NEWS

Mark Zuckerberg just had to eat several large helpings of crow.

And some minor political flap wasn’t on the menu. 

As the Wall Street Journal first reported, the CEO of Facebook and Meta expressed regret on such weighty matters as government-induced censorship and free speech.

It’s good for Zuck to accept some degree of responsibility, but it’s kinda too late. By about three years.

The admissions came in a letter to Jim Jordan, the House Judiciary chairman, and is a major win for the Republicans. The onetime Harvard whiz kid usually digs in defensively, with vague promises of future reform.

After the pandemic hit, Zuckerberg wrote, senior Biden administration and White House officials had ‘repeatedly pressured our teams for months to censor certain COVID-19 content, including humor and satire, and expressed a lot of frustration with our teams when we didn’t agree.’

That is an important distinction. The Biden pressure tactics didn’t always work. Facebook could, and sometimes did, say no. But much of the time, the giant social media site just caved.

And Facebook had a publicly proclaimed agenda: prodding millions of people to take Covid vaccines.

Zuckerberg said the administration pressure ‘was wrong, and I regret that we were not more outspoken about it.’ His company ‘made some choices that, with the benefit of hindsight and new information, we wouldn’t make today…I feel strongly that we should not compromise our content standards due to pressure from any administration in either direction — and we’re ready to push back if something like this happens again.’

I don’t know: How confident are you that Facebook would publicly push back on some hot-button issue today?

A Biden White House spokesman, in lawyerly language that didn’t quite respond to Zuck’s accusations, said it had ‘encouraged responsible actions to protect public health and safety…Our position has been clear and consistent: we believe tech companies and other private actors should take into account the effects their actions have on the American people, while making independent choices about the information they present.’

Two years ago, a Free Press reporter who examined the ‘Twitter Files’ found that both the Trump and the Biden administrations ‘directly pressed Twitter executives to moderate the platform’s pandemic content according to their wishes.’

One document mentioned the White House chief technology officer, who ‘led the Trump administration’s calls for help from the tech companies to combat misinformation.’

The piece also said that Facebook, Google and Microsoft joined in ‘weekly’ calls with the Trump officials to talk about ‘general trends’ at the companies. Sounds euphemistic.

But Trump was also a victim. Just four hours after a 2020 campaign video was posted and drew a half million views, Facebook took it down, saying it violated the social network’s policy against Covid misinformation. 

The Trump camp had posted a clip from a Fox interview in which the president said children were ‘virtually immune’ from the coronavirus. Most medical experts disagreed at the time.

‘They’ve got much stronger immune systems than we do somehow for this,’ Trump said. ‘They don’t have a problem. They just don’t have a problem.’

A White House spokeswoman at the time called the move ‘another display of Silicon Valley’s flagrant bias against this president, where the rules are only enforced in one direction.’

Zuckerberg, for his part, also made news on the Hunter Biden laptop.

He told Jordan that Meta ‘shouldn’t have demoted’ a New York Post story about the laptop shortly before the 2020 election. 

Let me stop right there. Demoted is tech jargon for suppressing a story, blatantly burying it so that few if any users see it. This happened after Twitter, as you’ll recall, totally blocked the Post story.

Trump allies got access to the laptop from the Delaware computer shop owner, at a time when Biden was the Democratic nominee. Dozens of former intelligence officials signed a letter dismissing the laptop story as fake, and in a debate with Trump, Biden said the release of the emails had ‘all the classic earmarks of a Russian information operation.’

Zuckerberg writes: ‘It’s since been made clear that the reporting was not Russian disinformation, and in retrospect, we shouldn’t have demoted the story.’

Right. And it took the New York Times and Washington Post another year and a half to ‘authenticate’ the laptop’s contents.

In the 2020 election, Zuck funded nonprofits to set up Covid-era voting booths and equipment sorting mail-in ballots, which Republicans, calling it ‘Zuckerbucks,’ argued with some justification that this unfairly benefited Democratic areas. Zuckerberg now says he won’t repeat the effort this time.

 

Trump said in a posting last month: ‘All I can say is that if I’m elected president, we will pursue Election Fraudsters at levels never seen before, and they will be sent to prison for long periods of time. We already know who you are. DON’T DO IT! ZUCKERBUCKS, be careful!’

In his Mar-a-Lago interview with me, Trump made his distaste for Facebook quite clear, in fact using it to justify dropping his opposition to banning TikTok, saying that would only help Zuckerberg’s company.

Now some may dismiss all this as old news, given that the events date to the pandemic and the last election. But it raises fundamental questions that continue to reverberate today, when Elon Musk’s endorsement of Trump has prompted many liberals to leave or largely abandon X and join Threads, the Zuckerberg copycat site.

Politicians and special interests routinely lobby the federal government. But when they use their considerable clout to pressure tech giants – secretly, behind closed doors, shielded from the public – it is deeply troubling.

This post appeared first on FOX NEWS

1844 Resources Inc. (TSXV: EFF) (the ‘Company’ or ‘1844’) is extremely pleased to announce the addition of Mr. Andre Gauthier to the board of directors effective immediately. [1]

Mr. Gauthier holds a B.Sc. in Geological Engineering and a M. Sc. in Mineral Exploration both obtained from the UQAC – Chicoutimi, (Québec) and is an active member and leader of many mining and professional organizations (Canada, Peru, UAE, and China).

Mr. Sylvain Laberge, President and CEO of 1844 states ‘On behalf of our board of directors, I would like to welcome Mr. Gauthier. His impressive resume over the span of his career, along with his experience and knowledge of both company and resource development in Quebec further strengthens our already strong team.’

Mr. Gauthier’s career has spanned 50 years and projects in over 35 countries. He has held senior positions, including officer and directors’ appointments in SOQUEM, Falconbridge, Noramco Mining, Cambior Inc., Maxy Gold Corp (China), Inca Pacific Resources, Lara Exploration Ltd., Vena Resources Inc., and Western Union Peru.

Additionally, Mr. Gauthier has been involved in many Gold and Copper discoveries and acquisitions, including Lac Shortt (Canada), La Arena (Peru), Anabi Minaspata (Peru), Luchun (China), Metates (Mexico), La Granja and La Virgen (Peru) and Pachon (Argentina).

Since 2020, Andre has been leading Eval Minerals, his private company involved in mineral investment and advisory. He is on the board of various companies involved in the exploration industry, both privately owned or listed on the Canadian Stock exchange. Since April 2024 Andre is also vice president of CAUR Technologies, a revolutionary Seismic technology which is part of Geophysics GPR International.

About 1844 Resources Inc: 

1844 is an exploration company with a focus in strategic and energetic metals and underexplored regions ‘Gaspé, Nunavik Québec’.  With a dedicated management team, the Company’s goal is to create shareholder value through the discovery of new deposits.

1844 Resources Inc.

(signed) ‘Sylvain Laberge’               

Sylvain Laberge
President and CEO
514.702.9841
Slaberge@1844resources.com

FORWARD LOOKING INFORMATION

This news release includes ‘forward-looking statements’ and ‘forward-looking information’ within the meaning of Canadian securities legislation. All statements included in this news release, other than statements of historical fact, are forward-looking statements including, without limitation, statements with respect to the expected closings of the Unit Offering and the Option Agreement and the receipt of regulatory approval, including approval by the Exchange. Forward-looking statements include predictions, projections and forecasts and are often, but not always, identified by the use of words such as ‘anticipate’, ‘believe’, ‘plan’, ‘estimate’, ‘expect’, ‘potential’, ‘target’, ‘budget’ and ‘intend’ and statements that an event or result ‘may’, ‘will’, ‘should’, ‘could’ or ‘might’ occur or be achieved and other similar expressions and includes the negatives thereof.

Forward-looking statements are based on several assumptions and estimates that, while considered reasonable by management based on the business and markets in which the Company operates, are inherently subject to significant operational, economic, and competitive uncertainties, risks and contingencies. These include assumptions regarding, among other things: general business and economic conditions; the availability of additional exploration and mineral project financing; and Exchange approval.

There can be no assurance that forward-looking statements will prove to be accurate and actual results, and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company’s expectations include exploration or other risks detailed from time to time in the filings made by the Company with securities regulators, including those described under the heading ‘Risks and Uncertainties’ in the Company’s most recently filed MD&A. The Company does not undertake to update or revise any forward-looking statements, except in accordance with applicable law.

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

[1] The Company’s Articles allow for the increase in the size of the Company’s board of directors by 1/3 between annual general meetings. Pursuant to the Company’s Articles, the Company’s board of directors was increased from five directors to six directors.

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/221242

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

Artemis Gold (TSXV:ARTG,OTC Pink:ARGTF) has reportedly been directed by BC’s Environmental Assessment Office (EAO) to dismantle an unauthorized worker camp at its Blackwater gold asset.

According to CBC, the camp, which has at least 48 accommodation units and is located 110 kilometers south of Vanderhoof, BC, is not in compliance with provincial regulations following an on-site inspection.

The inspection took place on May 14 and showed that the camp is not permitted under Artemis’ environmental certificate. Blackwater’s existing certificate allows for a main construction camp accommodating up to 1,000 workers and an operations camp for 500 workers, both of which must be located within designated site boundaries.

The camp, located at the Chu site, also contains three generators and potable water storage. It was established to support workers involved in the construction of the Blackwater project’s transmission line.

CBC notes that Artemis acknowledged the situation through a statement, explaining that the camp was set up after the company received a permit transfer from a previous holder in March of this year. The site had been abandoned by its previous occupant, and Artemis invested US$200,000 in site remediation, including the removal of old infrastructure.

The company also said the camp was intended as a temporary arrangement to support construction efforts. When the non-compliance was identified by the EAO, Artemis was ordered to cease operations at the site by August 7.

However, the EAO granted an extension to August 21, allowing wildfire contractors to use the camp temporarily due to emergency operations in the area. The camp must be fully dismantled by 6:00 p.m. PDT on August 31.

Artemis has said work is already underway to comply with the order. Workers previously housed at the camp have been relocated to the main construction camp at the Blackwater site.

The Blackwater project is one of BC’s largest mining developments. It is expected to produce gold and silver for over 17 years, with a daily milling capacity of 60,000 metric tons. Construction of the project was approximately 87 percent complete as of a July 30 update, with first gold production targeted for the fourth quarter of the year.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Aura Minerals (TSX:ORA,OTCQX:ORAAF) announced plans to delay the start of construction at its Matupá gold project in Brazil after acquiring the right to explorethe Pezão and Pé Quente projects in mid-May.

The company said it is revising its strategy in order to maximize the region’s geological potential. In addition to its plans for Pezão and Pé Quente, Aura is conducting ongoing exploration at the Serrinhas and X2 targets.

Pezão and Pé Quente cover six mineral rights and span over 28,000 hectares in the Alta Floresta gold province. The company said in its mid-May announcement that it was planning to invest US$1.6 million over 12 months to complete 13,000 meters of drilling at the assets. Its goal is to further assess mineralization continuity and grades.

Historical data from the Pezão and Pé Quente sites suggests they contain gold mineralization, though Aura notes that these figures have not yet been confirmed through modern exploration techniques.

With the delay in construction at Matupá, Aura is withdrawing its projection that it will be able to produce 450,000 gold equivalent ounces annually by the end of 2025. However, it expects to exceed that level in the coming years.

CEO Rodrigo Barbosa explained in a press release that the decision to postpone construction reflects the company’s commitment to optimizing its capital investments in favor of shareholder benefits.

‘The decision to postpone the Matupá construction reflects our strategy of maximizing the returns on the invested capital. We recognize the significant geological potential of the region, which could substantially increase returns of the Project to our shareholders,” he stated in the company’s Monday (August 26) announcement.

In the meantime, Aura remains focused on increasing productivity across its existing operations.

The company noted that it has already made strides in expanding the production capacity of its Brazil-based Almas gold mine, where it commenced operations in August 2023. Almas’ initial capacity of 1.3 million metric tons per year is expected to increase to 1.8 million metric tons by 2025. It currently stands at 1.5 million metric tons.

Aura is also advancing construction of the Borborema gold project, with output set to begin in early 2025.

Currently the company operates four mines across the Americas. In addition to Almas, it holds the Aranzazu copper-gold-silver mine in Mexico, the Minosa (San Andres) gold mine in Honduras and the Apoena (EPP) gold mine in Brazil.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Gary Wagner, executive producer TheGoldForecast.com, shared his outlook for gold, using technical analysis to explain how the yellow metal could rise to the US$2,700 per ounce level by the first quarter of 2025.

He also discussed the US Federal Reserve’s upcoming interest rate turnaround and what it means for gold.

‘To me what is most important is not that they’re signaling a rate cut in September — it’s much more than that,’ said Wagner, who is also a frequent Kitco News contributor. ‘They are signaling a major pivot from a highly restrictive to a highly accommodative monetary policy that’s end goal is interest rate normalization.’

When it comes to silver, Wagner said its previously high correlation with gold has dissipated. While he’s perplexed about why this has happened, he believes US$33 per ounce has essentially become the new US$50 for silver.

‘My sense is a breakout would have to occur after we have a solid base in silver above US$30. If that’s the case, we would have to see if it continues to climb — how it reacts to US$33 and US$32,’ he explained.

‘I think that the first area of resistance comes in around US$30, and then US$33. I would need to see silver break above US$33 on a closing basis for a period of time — a week, 10 days — before I would feel bullish enough about silver to say the next price level is now going to be where silver moves to. And that would be US$40,’ Wagner added.

Watch the interview above for more from Wagner on gold, silver and the US economy.

Securities Disclosure: I, Charlotte McLeod, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Longevity research companies are working to promote healthy aging and extend life expectancy.

A long, healthy life is something everyone has a vested interest in, but that doesn’t mean it’s always easy to get into longevity investing. Many longevity research companies remain private, meaning it’s difficult for the average person to secure a stake.

However, investors shouldn’t ignore private companies in the longevity sector, as they represent a potential opportunity to gain exposure to rapid growth in a sector that touches diverse life science markets.

These private longevity research companies are working on innovative studies and employing technologies such as AI to target diseases associated with aging, including cardiovascular disease, type 2 diabetes and various cancers. If they do go public one day, investors who have them on their radar already will be ahead of the game.

Here’s a short list of some of the top private longevity research companies making headlines today.

1. Altos Labs

Based in Los Altos, California, Altos Labs is a biotechnology company that is developing cellular rejuvenation programming to promote healthy cells in the human body and revive cells damaged by environmental stresses. The company is also establishing operations in San Diego and the UK, and is working on collaborations in Japan.

Launched after a US$3 billion investment round in early 2022, Altos Labs reportedly has the backing of big-name investors, including Amazon’s (NASDAQ:AMZN) Jeff Bezos. Altos Labs CEO Hal Barron is the former president of research and development and chief scientific officer for the pharmaceutical giant GlaxoSmithKline (LSE:GSK,NYSE:GSK).

The company has stacked its team with some of the world’s leading scientists, including: Jennifer Doudna, the co-winner of the 2020 Nobel prize in chemistry for the development of the gene-editing tool CRISPR; and Shinya Yamanaka, the winner of the 2012 Nobel prize in medicine for stem cell research.

‘Altos seeks to decipher the pathways of cellular rejuvenation programming to create a completely new approach to medicine, one based on the emerging concepts of cellular health,’ said Rick Klausner, chief scientist and founder of Altos Labs and the former director of the National Cancer Institute.

In research work from March, scientists from Altos Labs and Cambridge Institute of Science uncovered why vertebrates such as humans make myelin, a fatty acid that protective the axons of nerve cells in the human brain, enabling our species to quickly process information. Their study revealed that myelin production is regulated by a molecular parasite called RNLTR12-int, which is believed to have infected a common ancestor.

2. Arena BioWorks

Biomedical research institute Arena BioWorks is one of the newest longevity-focused private firms on this list. Located in the Kendall Square biotech hub in Cambridge, Massachusetts, Arena BioWorks aims “to uncover mechanisms of disease by engaging in basic biological research that will be translated into lifesaving biotech therapeutics” across a broad range of indications including brain health, oncology, immunology and aging.

The company’s business model revolves around both collaborative drug discovery and the creation of for-profit biotech firms.

Arena BioWorks’ co-founders include Harvard chemical biology scientist and Broad Institute co-founder Stuart Schreiber, former Bain Capital Co-Chair Steve Pagliuca, and Tom Cahill, co-founder and Managing Director of life science venture capital firm Newpath Partners. Dr. Keith Joung, a leader in the field of CRISPR gene editing, is a member of the scientific team. Dell (NYSE:DELL) CEO Michael Dell and venture capitalist Jim Breyer are notable investors.

‘Arena’s single source of funding frees our scientists from the typical short-term cycles of grant and venture capital funding,” Schrieber said of his company’s privately funded model. “Our aim is to accelerate progression from deep mechanistic human biology to biotech-enabled drug development.’

3. Cellular Longevity

San Francisco-based company Cellular Longevity, doing business as Loyal, is a clinical-stage veterinary medicine company developing therapies aimed at extending the lifespan of man’s best friend: dogs.

Led by a team of experienced veterinarians, the company has three products in its pipeline targeting the underlying causes of aging in dogs and expects to bring its first product to market in 2025 with US FDA conditional approval.

Loyal’s LOY-001 is a longevity drug designed to increase the lifespans of large and giant breed dogs for which the company has FDA permission to research and conduct clinical trials. Large and giant breed dogs tend to age faster and have shorter lifespans as they are more prone to certain cancers and musculoskeletal issues compared to smaller breeds. In November 2023, the FDA determined based on early data that the drug has a “reasonable expectation of effectiveness.”

The Wall Street Journal reported in March of this year that Loyal had secured US$45 million in equity from venture capital funds.

4. Insilico Medicine

Hong Kong-based Insilico Medicine is a clinical-stage biotech company harnessing the power of artificial intelligence (AI), big data analysis and genomics for researching aging and developing medicines that target cancers, infectious diseases, autoimmune diseases, central nervous system diseases and age-related diseases. The firm was named Top Biotech Company in Fast Company’s 2024 list of the world’s most innovative companies.

Insilico uses its AI platforms to help identify and develop new drug candidates for untreated diseases and then predict how well those treatments may perform in clinical trials. In November 2022, Insilico signed a strategic research collaboration with Sanofi (NASDAQ:SNY) worth up to US$1.2 billion, with its value depending on certain milestones being met.

The company has a large pipeline of drug candidates targeting a variety of conditions. Its most advanced program is for idiopathic pulmonary fibrosis, which is a type of chronic scarring lung disease characterized by a progressive and irreversible decline in lung function.

In April this year, Insilico initiated a program, supported by its generative AI drug design engine Chemistry42, to develop a novel PTPN2/N1 inhibitor with drug-likeness properties and in vivo oral absorption. The research was published in the European Journal of Medicinal Chemistry.

In July, the company launched its AI-powered hardware platform, PandaOmics Box, designed for on-premise drug discovery and personalized medicine research. “We offer on-premise PandaOmics Box that supports scientists to conduct cutting-edge tasks such as target identification, biomarker discovery, and indication prioritization in one hardware with no internet connection,” said Alex Zhavoronkov, PhD, founder and CEO of Insilico Medicine.

5. Retro Biosciences

Another biotech Headquartered in San Francisco, Retro Biosciences is specializing in cellular reprogramming, autophagy and plasma-inspired therapeutics on a mission to increase healthy human lifespans by 10 years. “By focusing on the cellular driver of aging, Retro will produce therapeutics eventually capable of multi-disease prevention,” according to the company.

Of its three main areas of focus, Retro’s cellular reprogramming work is the most advanced, and the company plans to work towards a clinical proof-of-concept over the next four years.

Retro is backed by an all-star team headed by CEO Joe Betts-LaCroix. Betts-LaCroix was a co-founder of OQO, the company that created the then-smallest personal Windows PC in 2000; he also founded the Health Extension Foundation. Retro co-founder Sheng Ding is a professor in the Department of Pharmaceutical Chemistry at the University of California, San Francisco, while co-founder Matt Buckley was formerly a systems integration engineer with life science firm Illumina (NASDAQ:ILMN), as well as a scientist with Global Biologics Development at Bayer Pharmaceuticals.

Retro Biosciences’ biggest investor is OpenAI’s Sam Altman, who reportedly put up US$180 million in venture funding. The money is expected to take its cellular reprogramming work through clinical proof-of-concept.

This May, Retro and robotics company Multiply Labs inked an US$85 million dollar partnership to advance the automation of the manufacturing of cell therapies, including CAR-T therapies, for age-related diseases. “The accelerating rate of change in cell therapies motivated us to look for a manufacturing platform with flexibility at its core,” said Retro CEO Joe Betts-LaCroix. “The modular structure of the Multiply Labs robots will help enable Retro to bring its unique cell therapies to patients.”

Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Cryptocurrencies such as Bitcoin and Ethereum offer an alternative route for building and storing wealth. While directly holding these digital assets is a popular option, investors are also clamoring for financial products such as crypto exchange-traded funds (ETFs).

Canada first launched Bitcoin and Ethereum ETFs in 2021. These Canadian Bitcoin and Ethereum ETFs allow investors to place returns in tax-sheltered accounts like tax-free savings accounts or registered retirement savings plans.

“There is a high demand for a Bitcoin product that has all the features that people love about ETFs — that they trade on an exchange, that they’re liquid,” Ross Mayfield, investment strategy analyst at Robert W. Baird & Co., told Bloomberg in mid-2021.

Interest has only increased since then. Sean Farrell, head of digital asset strategy at Fundstrat, wrote in mid-2023 that the Bitcoin ETF category at large has the potential to surpass the precious metals ETF market in terms of asset value. ‘Bitcoin ETF eventually could become >$300 billion category,’ he stated in the note.

Ethereum ETFs have also picked up steam and become a major talking point. Ethereum is the most widely used blockchain technology, and Ether, the digital currency of this platform, is the second largest cryptocurrency after Bitcoin.

With that in mind, it’s worth taking a look at the currently available Canadian cryptocurrency ETFs. The list below includes 13 options available on the Canadian market sorted by assets under management, and all data presented is current as of August 23, 2024.

1. Purpose Bitcoin ETF (TSX:BTCC)

Company Profile

Assets under management: C$2.3 billion

Billed as the world’s first physically settled Bitcoin ETF, the Purpose Bitcoin ETF launched in February 2021 and is backed by Bitcoin in cold storage. This means the fund allows investors to add and sell Bitcoin with no digital wallet required.

Hosted by Canadian investment company Purpose Investments, the Purpose Bitcoin ETF is backed by 26,983.5 Bitcoins and has a management expense ratio of 1 percent.

2. CI Galaxy Bitcoin ETF (TSX:BTCX.B)

Company Profile

Assets under management: C$754.17 million

Launched in March 2021, the CI Galaxy Bitcoin ETF was born out of a partnership between cryptocurrency leaders Galaxy Fund Management and CI Global Asset Management. Galaxy Fund Management is part of Galaxy Digital, a diversified financial services firm with a focus on digital assets and the blockchain technology sector.

The ETF’s objective is to give investors exposure to Bitcoin via an institutional-quality fund platform, as its holdings are wholly Bitcoin and are kept in cold storage. At 0.4 percent, this fund boasts one of the lowest management fees of all the crypto funds on the market.

3. Fidelity Advantage Bitcoin ETF (TSX:FBTC)

Company Profile

Assets under management: C$506.30 million

The newest Bitcoin fund on this list, the Fidelity Advantage Bitcoin ETF, launched in November 2021. It offers the security of Fidelity’s in-house cold storage services for its holdings.

While it previously had a management fee of 0.4 percent, in line with the CI and Galaxy funds, the Fidelity Advantage Bitcoin ETF lowered it in January 2024 to an ultra-low management fee of 0.39 percent.

4. CI Galaxy Ethereum ETF (TSX:ETHX.B)

Company Profile

Assets under management: C$455.29 million

The CI Galaxy Ethereum ETF, another collaboration between CI and Galaxy, offers investors exposure to the spot Ethereum price through Ether holdings in cold storage. The fund launched on April 20, 2021, the same day as two of the other Ether ETFs on this list.

At the time, CI Global Asset Management suggested that “owning Ether is similar to owning a basket of early-stage, high-growth technology stocks.”

The CI Galaxy Ethereum ETF has notably low management fees of just 0.4 percent.

5. Purpose Ether ETF (TSX:ETHH)

Company Profile

Assets under management: C$369.30 million

The Purpose Ether ETF is a direct-custody Ether ETF that launched on April 20, 2021. This fund holds 98,611 Ether, which it stores in cold storage.

The Purpose Ether ETF offers investors exposure to the daily price movements of physically settled Ether tokens with a management fee of 1 percent.

6. 3iQ CoinShares Bitcoin ETF (TSX:BTCQ)

Company Profile

Assets under management: US$‪299.41 million

Launched in March 2021, the 3iQ CoinShares Bitcoin ETF tracks the price movement of Bitcoin in US dollar terms, and holds its Bitcoin assets in cold storage. This ETF has a management fee of 1 percent. Figures for this ETF were accurate as of July 31 2024, according to the fund’s website.

7. Evolve Bitcoin ETF (TSX:EBIT)

Company Profile

Assets under management: C$223.38 million

Evolve ETFs partnered with cryptocurrency experts, including Gemini Trust Company, CF Benchmarks, Cidel Bank & Trust and CIBC Mellon Global Services, to launch the Evolve Bitcoin ETF. The fund, which holds its own Bitcoin, has a management fee of 0.75 percent.

Launched a week after the Purpose Bitcoin ETF, its holdings of Bitcoin are priced based on the CME CF Bitcoin Reference Rate, a once-a-day benchmark index price for Bitcoin denominated in US dollars.

8. Purpose Bitcoin Yield ETF (TSX:BTCY)

Company Profile

Assets under management: C$105.5 million

The Purpose Bitcoin Yield ETF uses a covered call strategy to generate yield for investors, which involves writing call options on Bitcoin. Call options give the buyer an option to purchase an asset at a specific price on or before a specific date.

Its structure allows the fund to earn income from option premiums while providing investors with exposure to Bitcoin’s price movements. Its distributions are paid monthly.

9. Purpose Ether Yield ETF (TSX:ETHY)

Company Profile

Assets under management: C$63.4 million

Like the Purpose Bitcoin Yield ETF, the Purpose Ether Yield ETF offers investors an opportunity to invest in Ether while also generating yield. Purpose Investments lends a portion of its Ether holdings to institutional borrowers and earns interest on those loans.

Investors who purchase shares of this ETF receive a portion of the interest earned in monthly distributions.

10. Evolve Ether ETF (TSX:ETHH)

Company Profile

Assets under management: C$63.04 million

The Evolve Ether ETF offers investors an easier route to investing directly in Ether. The fund’s holdings of Ether are priced based on the CME CF Ether-Dollar Reference Rate, a once-a-day benchmark index price for Ether denominated in US dollars. As with the Evolve Bitcoin ETF, the Evolve Ether ETF has a management fee of 0.75 percent.

11. 3iQ CoinShares Staking Ether ETF (TSX:ETHQ)

Company Profile

Assets under management: C$‪62.3 million

Following the success of its Bitcoin ETF, 3iQ Digital Asset Management launched its CoinShares Ether ETF in April 2021. This fund has a similar objective, offering exposure to Ether and its daily US dollar price movements. It also has a management fee of 1 percent.

Figures for this fund were accurate as of July 31, 2024, according to the fund’s website.

12. Evolve Cryptocurrencies ETF (TSX:ETC)

Company Profile

Assets under management: C$39.09 million

The Evolve Cryptocurrencies ETF launched in September 2021 as the first multi-cryptocurrency ETF, providing combined exposure to both Bitcoin and Ether.

This product from Evolve ETFs allows investors to diversify their crypto portfolios and provides indirect exposure to the two coins, weighing them by market capitalization and rebalancing its holdings on a monthly basis. Bitcoin makes up the majority of its portfolio.

While this ETF has no management fee, the underlying funds that hold both Bitcoin and Ether have management fees of 0.75 percent plus applicable taxes.

13. Fidelity Advantage Ether ETF (TSX:FETH)

Company Profile

Assets under management: C$21.4 million

Following the successful launch of its Bitcoin fund, Fidelity brought its Advantage Ether ETF to market in September 2022, making this the newest Ether ETF in Canada. Its holdings are stored in Fidelity’s in-house cold storage.

The Fidelity Advantage Ether ETF has a management fee of 0.4 percent.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com